GB Patent

GB201619637D0 — C3a receptor agonists

Assigned to Pekna Marcela And Pekny Milos And Stokowska Anna · Expires 2017-01-04 · 9y expired

What this patent protects

Patent listed against dihydroergotamine-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
GB201619637D0
Jurisdiction
GB
Classification
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Pekna Marcela And Pekny Milos And Stokowska Anna
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.